Founded in Shanghai in 2002, GBI has built a diverse portfolio of market intelligence solutions for pharmaceutical and device companies and other service providers. Focused on China and the Latin American markets, GBI’s value-added industry information, news, and data services power individuals and organizations’ decision-making and enable more effective communication. As a trusted source of information, GBI has become the preferred partner of more than 95% of multinational pharmaceutical companies, domestic leading pharmaceutical companies, consulting companies and other lighthouse users in the medical circle.